Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein β and transactivator islet duodenum homeobox- 1 in rat pancreatic β cells during the development of diabetes mellitus

Journal of Clinical Investigation

Volumn 101, Issue 11, 1998, Pages 2528-2539

  Seufert, Jochen ^a   Weir, Gordon C ^b   Habener, Joel F ^a,c  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b JOSLIN DIABETES CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Diabetes mellitus; Glucose toxicity; Insulin gene; Lipotoxicity; Transcription factors

Indexed keywords

BINDING PROTEIN; HOMEODOMAIN PROTEIN; INSULIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; DOWN REGULATION; DUODENUM; ENHANCER REGION; GENE EXPRESSION; HYPERGLYCEMIA; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA TRANSLATION; TRANSCRIPTION REGULATION;

EID: 0032103208     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2401     Document Type: Article

References (68)

1. Robertson, R.P., L.K. Olson, and H.J. Zhang. 1994. Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes. 43:1085-1089.
2. Leahy, J.L., S. Bonner-Weir, and G.C. Weir. 1992. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care. 15:442-455.
3. Olson, L.K., J.B. Redmon, H.C. Towle, and R.P. Robertson. 1993. Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J. Clin. Invest. 92:514-519.
4. Eizirik, D.L., G.S. Korbutt, and C. Hellerstrom. 1992. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J. Clin. Invest. 90:1263-1268.
5. Leahy, J.L., and G.C. Weir. 1991. Beta-cell dysfunction in hyperglycemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level. Diabetologia. 34:640-647.
6. Poitout, V., L.K. Olson, and R.P. Robertson. 1996. Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J. Clin. Invest. 97:1041-1046.
7. Sharma, A., L.K. Olson, R.P. Robertson, and R. Stein. 1995. The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression. Mol. Endocrinol. 9:1127-1134.
8. Olson, L.K., A. Sharma, M. Peshavaria, C.V. Wright, H.C. Towle, R.P. Robertson, and R. Stein. 1995. Reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to a supraphysiologic glucose concentration is associated with loss of STF-1 transcription factor expression. Proc. Natl. Acad. Sci. USA. 92:9127-9131.
9. Moran, A., H.J. Zhang, L.K. Olson, J.S. Harmon, V. Poitout, and R.P. Robertson. 1997. Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line. H1T-T15. J. Clin. Invest. 99:534-539.
10. Lu, M., J. Seufert, and J.F. Habener. 1997. Pancreatic β-cell specific repression of insulin gene transcription by CCAAT/enhancer-binding protein β (C/EBPβ): inhibitory interactions with basic helix-loop-helix factor E47. J. Biol. Chem. 272:28349-28359.
11. Olson, L.K., V. Poitout, and R.P. Robertson. 1996. Glucose rapidly and reversibly decreases INS-1 cell insulin gene transcription via decrements in STF-1 and C1 activator transcription factor activity. Mol. Endocrinol. 12:207-219.
12. Zangen, D.H., S. Bonner-Weir, C.H. Lee, J.B. Latimer, C.P. Miller, J.F. Hanener, and G.C. Weir. 1997. Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial panereatectomy. Diabetes. 46:258-264.
13. Hirose, H., Y.H. Lee, L.R. Inman, Y. Nagasawa, J.H. Johnson, and R.H. Unger. 1996. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J. Biol. Chem. 271:5633-5637.
14. Lee, Y., H. Hirose, M. Ohneda, J.H. Johnson, J.D. McGarry, and R.H. Unger. 1994. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc. Natl. Acad. Sci. USA. 91:10878-10882.
15. Gremlich, S., C. Bonny, G. Waeber, and B. Thorens. 1997. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J. Biol. Chem. 272:30261-30269.
16. Philippe, J. 1994. Pancreatic expression of the insulin and glucagon genes: update 1994. Endocr. Rev. 2:21-27.
17. Steiner, D.F., S.J. Chan, J.M. Welsh, and S.C. Kwok. 1985. Structure and evolution of the insulin gene. Annu. Rev. Genet. 19:463-484.
18. Miller, C.P., R.E. McGehee, Jr., and J.F. Habener, 1994. IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO (Eur. Mol. Biol. Organ.) J. 13:1145-1156.
19. Karlsson, O., T. Edlund, J.B. Moss, W.J. Rutter, and M.D. Walker. 1987. A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer. Proc. Natl. Acad. Sci. USA. 84:8819-8823.
20. Ohlsson, H., and T. Edlund. 1986. Sequence-specific interactions of nuclear factors with the insulin gene enhancer. Cell. 45:35-44.
21. Peers, B., J. Leonard, S. Sharma, G. Teitelman, and M.R. Montminy. 1994. Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1. Mol. Endocrinol. 8:1798-1806.
22. Alam, T., M.R. An, and J. Papaconstantinou. 1992. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J. Biol. Chem. 267:5021-5024.
23. Mandrup, S., and M.D. Lane. 1997. Regulating adipogenesis. J. Biol. Chem. 272:5367-5370.
24. Raught, B., W.S.L. Liao, and J.M. Rosen. 1995. Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence β-casein gene expression. Mol. Endocrinol. 9:1223-1232.
25. Muller, C., E. Kowenz-Leutz, S. Grieser-Ade, T. Graf, and A. Leutz. 1995. NF-M (chicken C/EBP beta) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line. EMBO (Eur. Mol. Biol. Organ.) J. 14:6127-6135.
26. Wedel, A., and H.W. Ziegler-Heitbrock. 1997. The C/EBP family of transcription factors. Immunobiology. 193:171-185.
27. Pei, D.Q., and C.H. Shih. 1990. Transcriptional activation and repression by cellular DNA-binding protein C/EBP. J. Virol. 64:1517-1522.
28. Kava, R., M.R.C. Greenwood, and P.R. Johnson. 1990. Zucker (fa/fa) rat. ILAR News. 32:4-8.
29. Orland, M.J., R. Chyn, and M.A. Permutt. 1985. Modulation of proinsulin messenger RNA after partial pancreatectomy in rats. Relationships to glucose homeostasis. J. Clin. Invest. 75:2047-2055.
30. Fehmann, H.C., and J.F. Habener. 1991. Homologous desensitization of the insulinotropic glucagon-like peptide-I (7-37) receptor of insulinoma (HIT-T15) cells. Endocrinology. 128:2880-2888.
31. Kieffer, T.J., R.S. Heller, C.G. Unson, G.C. Weir, and J.F. Habener. 1996. Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets. Endocrinology. 137:5119-5125.
32. Gotoh, M., T. Maki, S. Satomi, J. Porter, S. Bonner-Weir, C.J. O'Hara. and A.P. Monaco. 1987. Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplantation (Baltimore). 43:725-730.
33. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
34. Ron, D., and J.F. Habener. 1992. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6:439-453.
35. Chan, S.J., B.E. Noyes, K.L. Agarwal, and D.F. Steiner. 1979. Construction and selection of recombinant plasmids containing full-length complementary DNAs corresponding to rat insulins I and II. Proc. Natl. Acad. Sci. USA. 76:5036-5040.
36. Zimmermann, K., and J.W. Mannhalter. 1996. Technical aspects of quantitative competitive PCR. Biotechniques. 21:268-279.
37. Tokuyama, Y., J. Sturis, A.M. DePaoli, J. Takeda, M. Stoffel, J. Tang, X. Sun, K.S. Polonsky, and G.I. Bell. 1995. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes. 44:1447-1457.
38. Iida, M., T. Murakami, K. Ishida, A. Mizuno, M. Kuwajima, and K. Shima. 1996. Substitution at codon 269 (glutamine → proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat. Biochem. Biophys. Res. Commun. 224:597-604.
39. Phillips, M.S., O. Liu, H.A. Hammond, V. Dugan, P.J. Hey, C.J. Caskey, and J.F. Hess. 1996. Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet. 13:18-19.
40. Takaya, K., Y. Ogawa, N. Isse, T. Okazaki, N. Satoh, H. Masuzaki, K. Mori, N. Tamura, K. Hosuda, and K. Nakao. 1996. Molecular cloning of rat leptin receptor isoform complementary DNA's identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem. Biophys. Res. Commun. 225:75-83.
41. White, D.W., Y. Wang, S.C. Chua, J.P. Morgenstern, R.L. Leibel, H. Baumann, and L.A. Tartaglia. 1997. Constitutive and impaired signaling of leptin receptors containing the Gin-Pro extracelluar domain fatty mutation. Proc. Natl. Acad. Sci. USA. 44:10567-10662.
42. Bonner-Weir, S., D.F. Trent, and G.C. Weir. 1983. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J. Clin. Invest. 71:1544-1553.
43. Poitout, V., and R.P. Robertson. 1996. An integrated view of beta-cell dysfunction in type-II diabetes. Annu. Rev. Med. 47:69-83.
44. Leahy, J.L., and G.C. Weir. 1988. Evolution of abnormal insulin secretory responses during 48-h in vivo hyperglycemia. Diabetes. 37:217-222.
45. Ling, Z., R. Kiekens, T. Mahler, F.C. Schuit, M. Pipeleers-Marichal, A. Sener, G. Kloppel, W.J. Malaisse, and D.G. Pipeleers. 1996. Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes. 45:1774-1782.
46. Ling, Z., and D.G. Pipeleers. 1996. Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J. Clin. Invest. 98:2805-2812.
47. Permutt, A., J. Chirgwin, S. Giddings, K. Kakita, and P. Rotwein. 1981. Insulin biosynthesis and diabetes mellitus. Clin. Biochem. 14:230-236.
48. Leahy, J.L., S. Bonner-Weir, and G.C. Weir. 1988. Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J. Clin. Invest. 81:1407-1414.
49. Unger, R.H. 1995. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes. 44:863-870.
50. Koyama, K., G. Chen, Y. Lee, and R.H. Unger. 1997. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am. J. Physiol. 273:E708-E713.
51. Zhou, Y.P., and V.E. Grill. 1994. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93:870-876.
52. Grupping, A.Y., M. Cnop, C.G. Van Schravendijk, J.C. Hannaert, T.J. Van Berkel, and D.G. Pipeleers. 1997. Low density lipoprotein binding and uptake by human and rat islet beta cells. Endocrinology. 138:4064-4068.
53. Milburn, J.L., Jr., H. Hirose, Y.H. Lee, Y. Nagasawa, A. Ogawa, M. Ohneda, H. BeltrandelRio, C.B. Newgard, J.H. Johnson, and R.H. Unger. 1995. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J. Biol. Chem. 270:1295-1299.
54. Shimabukuro, M., K. Koyama, G. Chen, M.Y. Wang, F. Trieu, Y. Lee, C.B. Newgard, and R.H. Unger. 1997. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. USA. 94:4637-4641.
55. Lee, Y., H. Hirose, Y.T. Zhou, V. Esser, J.D. McGarry, and R.H. Unger. 1997. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes. 46:408-413.
56. Wang, M.Y., K. Koyama, M. Shimabukuro, C.B. Newgard, and R.H. Unger. 1998. Ob-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. Proc. Natl. Acad. Sci. USA. 95:714-718.
57. Zhou, Y.T., M. Shimabukuro, Y. Lee, K. Koyama, F. Trieu, and R.H. Unger. 1997. Leptin normalizes the impaired response of proinsulin mRNA to long chain fatty acids in heterozygous Zucker diabetic fatty rats. J. Biol. Chem. 272:25648-25651.
58. Chen, G., K. Koyama, X. Yuan, Y. Lee, Y.T. Zhou, R. O'Doherty, C.B. Newgard, and R.H. Unger. 1996. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc. Natl. Acad. Sci. USA. 93:14795-14799.
59. Koyama, K., G. Chen, M.Y. Wang, Y. Lee, M. Shimabukuro, C.B. Newgard, and R.H. Unger. 1997. Beta-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. Diabetes. 48:1276-1280.
60. Shimabukuro, M., M. Ohneda, Y. Lee, and R.H. Unger. 1997. Role of nitric oxide in obesity-induced beta cell disease. J. Clin. Invest. 100:290-295.
61. Shimabukuro, M., K. Koyama, Y. Lee, and R.H. Unger. 1997. Leptin-or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity. J. Clin. Invest. 100:1750-1754.
62. Kajimoto, Y., H. Watada, T. Matsuko, H. Kaneto, Y. Fujitani, J. Miyazaki, and Y. Yamasaki. 1997. Suppression of transcription factor PDX-1/ IPF1/STF-1/IDX-1 causes no decrease in insulin mRNA in MIN6 cells. J. Clin. Invest. 100:1840-1846.
63. Watada, H., Y. Kajimoto, Y. Umayahara, T. Matsuoka, H. Kaneto, Y. Fujitani, T. Kamada, R. Kawamori, and Y. Yamasaki. 1996. The human glucokinase gene β-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes. 45:1478-1488.
64. Waeber, G., N. Thompson, P. Nicod, and C. Bonny. 1996. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol. Endocrinol. 10:1327-1334.
65. Watada, H., Y. Kajimoto, H. Kaneto, T. Matsuoka, Y. Fujitani, J. Miyazaki, and Y. Yamasaki. 1996. Involvement of the homeodomain-containing transcription factor PDX-1 in islet amyloid polypeptide gene transcription. Biochem. Biophys. Res. Commun. 229:746-751.
66. Jonsson, J., L. Carlsson, T. Edlund, and H. Edlund. 1994. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature. 371:606-609.
67. Stoffers, D.A., N.T. Zinkin, V. Stanojevic, W.L. Clarke, and J.F. Habener. 1997. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15:106-110.
68. Stoffers, D.A., J. Ferrer, W.L. Clarke, and J.F. Habener. 1997. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 17:138-139.